NEW YORK ( TheStreet) -- CHANGE IN RATINGS Aeropostale ( ARO) was upgraded at Topeka Capital to buy. $18 price target. New fashion is impressive, Topeka said. Choice Hotels ( CHH) was downgraded at Wells Fargo to underperform from market perform. Stock is trading at a 20% premium to its historical valuation, Wells Fargo said. Flir Systems ( FLIR) was downgraded at Drexel Hamilton to hold from buy. Stock is trading at historically high and unwarranted multiples, Drexel Hamilton said. Downgraded on valuation. Magellan Health Services ( MGLN) was downgraded at Citigroup to sell from neutral. The loss of four contracts account is not appropriately captured by consensus, Citi said. MBT) was upgraded to buy at TheStreet Ratings. Nasdaq ( NDAQ) was downgraded at Goldman Sachs to sell from neutral. Price target is $28. Shift to lower margin revenue sources will hurt future earnings, Goldman said. Netsuite ( N) was upgraded to hold at TheStreet Ratings. PulteGroup ( PHM) was upgraded at UBS to buy from neutral and given a $22 price target. The stock is undervalued given leverage from Del Webb, margin expansion and focus on maximizing returns, UBS said. PHM) was upgraded at Williams Financial Group to buy from hold. Price target is $21. Community count expansion is expected to drive new order growth. Perrigo ( PRGO) was upgraded to buy from hold at Deutsche Bank. $150 price target. Elan acquisition enhances the company's outlook, Deutsche said. Bankrate ( RATE) was upgraded to buy at Bank of America/Merrill Lynch. $22 price target. Trends are improving, and the stock is trading at an attractive valuation, BofA/Merrill said. Ryland Group ( RYL) was upgraded at UBS to buy from neutral and given a $48 price target. Higher ROE and improving profitability justify higher multiple, UBS said. SAVE) was downgraded at Citigroup to neutral from buy and given a $37 price target. Indigo Partners plans to sell all of its remaining shares, Citi said. Tumi ( TUMI) was initiated at Key Bank with a hold rating. The transition to a lifestyle brand and the addition of women's products are cited as the key growth factors, Key Bank said.
Franklin Resources ( BEN) numbers were reduced at UBS. Earnings estimates were reduced given slightly higher expenses and moderate IA fee pressure, said UBS. Price target goes to $59. Express Scripts ( ESRX) numbers were raised at UBS. Earnings estimates were raised to reflect raised guidance but slightly lower Rx claims growth, said UBS. Price target is $75. HIG) estimates, price target were raised at BofA/Merrill. Shares are now seen reaching $34. Estimates were also increased, given a better accident loss ration, BofA/Merrill said. Buy rating. Herbalife ( HLF) estimates, price target were increased at DA Davidson. Estimates were increased through 2014. Company is seeing better growth across the board, DA Davidson said. Buy rating and new $92 price target. Universal Display ( OLED) numbers were cut at JMP Securities. Shares are now seen reaching $39. Estimates were also reduced, given a slower growth outlook for Samsung, JMP said. Outperform rating. Plum Creek ( PCL) estimates were raised at UBS. Earnings estimates were boosted given upside in real estate, said UBS. Price target is $37. Vertex Pharmaceuticals ( VRTX) numbers were raised at UBS. Earnings estimates reflect an increased outlook for Kalydeco, said UBS. Price target is now $84. >To submit a news tip, email: firstname.lastname@example.org. Follow TheStreet on Twitter and become a fan on Facebook.